SynthesisThe Lancet. Haematology2020
Effects of the COVID-19 pandemic on supply and use of blood for transfusion.
Synthesis in The Lancet. Haematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 150 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
150 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Association of Anaesthetists guidelines: the use of blood components and their alternatives.Anaesthesia · 2025Guideline
- COVID-19 pandemic: health impact of staying at home, social distancing and 'lockdown' measures-a systematic review of systematic reviews.Journal of public health (Oxford, England) · 2021Pooled it
- Awareness about Coronavirus (COVID-19) and challenges for blood services among potential blood donors.Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2021Trial
- Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer.International journal of cancer · 2021Trial
- Proteomics of heterogeneous megakaryocytes identifies JI051 as an enhancer of platelet biogenesis.Life science alliance · 2026Article
- Thyroid hormones induce an acute platelet release mechanism via integrin αVβ3.Haematologica · 2026Article
- Article
- Application and retrospective analysis of the indicator system for non-conforming blood products in Beijing.Vox sanguinis · 2026Article
- Patient Blood Management in Total Hip and Knee Arthroplasty Before, During, and After the COVID-19 Pandemic: A Single-Center Retrospective Cohort Study.Medicina (Kaunas, Lithuania) · 2026Article
- Quality management of comprehensive blood conservation strategies during cardiopulmonary bypass in pediatric cardiac surgery.BMC anesthesiology · 2026Article
- Obstetric Outcomes of Jehovah's Witness Women Under Patient Blood Management: A Single-center, Propensity Score-Matched Cohort Study in Korea.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2026Article
- Forecasting blood supply and demand under population aging: implications and challenges for healthcare resource allocation.BMC health services research · 2026Article
- The ethics of blood stewardship and quantitative futility assessments to predict certain death in neurotrauma patients.Frontiers in medicine · 2026Review
- Donor type dynamics and associated factors among blood donors in northern Ghana: a six-year retrospective analysis.Frontiers in epidemiology · 2026Article
- Article
- Can drug-induced platelet dysfunction be reversed?Research and practice in thrombosis and haemostasis · 2026Review
- Mismatch between global patient blood management policy and nursing education: evidence from four countries.Frontiers in public health · 2026Article
- Article
- COVID-19 pandemic impact on blood donations and discards from screening tests for transfusion-transmitted infections in a Brazil Brazilian metropolitan area.Transfusion medicine (Oxford, England) · 2025Article
- Three buffy coat platelet concentrates: Use of data modelling to make more with less.Vox sanguinis · 2025Article
90 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic has major implications for blood transfusion. There are uncertain patterns of demand, and transfusion institutions need to plan for reductions in donations and loss of crucial staff because of sickness and public health restrictions. We systematically searched for relevant studies addressing the transfusion chain-from donor, through collection and processing, to patients-to provide a synthesis of the published literature and guidance during times of potential or actual shortage. A reduction in donor numbers has largely been matched by reductions in demand for transfusion. Contingency planning includes prioritisation policies for patients in the event of predicted shortage. A range of strategies maintain ongoing equitable access to blood for transfusion during the pandemic, in addition to providing new therapies such as convalescent plasma. Sharing experience and developing expert consensus on the basis of evolving publications will help transfusion services and hospitals in countries at different stages in the pandemic.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.